Please login to the form below

Not currently logged in
Email:
Password:

mCNV

This page shows the latest mCNV news and features for those working in and with pharma, biotech and healthcare.

Lucentis claims speedy FDA review for myopia complication

Lucentis claims speedy FDA review for myopia complication

Eylea is not yet approved for mCNV in the US, although Bayer has a green light for this use in Europe and so is already competing head-to-head with Novartis

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics